Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis
Elizabeth Baker, William T. Harris, Steven M. Rowe, Sarah B. Rutland, Gabriela R. Oates
Topics & Concepts
IvacaftorMedicineCystic fibrosisSmokeLung functionInternal medicineLungCystic fibrosis transmembrane conductance regulatorPhysicsMeteorologyCystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchRespiratory viral infections research